China NMPA Product Recall - TriGen InterTAN Hip Fracture Nailing System

Smith & Nephew, Inc. has initiated a voluntary Class II recall for its TriGen InterTAN Hip Fracture Nailing System. This recall, formally reported by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd., addresses a critical compatibility issue identified with the medical device. The specific models and specifications involved in this corrective action are thoroughly documented in a "Medical Device Recall Event Report Form." This regulatory event is overseen by the National Medical Products Administration (NMPA), as indicated by the NMPA Index No. JGXX-2025-10037 and a publication date of March 28, 2025. A key aspect of this recall is the assurance that the affected TriGen InterTAN Hip Fracture Nailing Systems were not imported into, nor distributed within, the Chinese market. This significantly mitigates any direct risk to patients in China. The Class II designation implies that the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. Smith & Nephew

’s proactive and voluntary recall underscores its commitment to patient safety and product quality, aligning with global regulatory expectations for medical device manufacturers. The NMPA's role in publicizing such events, even when products are not domestically distributed, highlights its comprehensive oversight responsibilities for medical device safety and quality management. This action ensures transparency and accountability within the medical device industry.